Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer.
R Escudero-ÁvilaJ D Rodríguez-CastañoI OsmanF FernandezR MedinaB VargasM Japón-RodríguezP SanchoB Perez-ValderramaJ M Praena-FernándezIgnacio DuranPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2018)
The clinical outcomes of patients with CSI GCTC managed by AS in this series were excellent. This strategy limited the administration of active treatments specifically to the minority of patients who relapsed without compromising performance.